Article Dans Une Revue PLoS ONE Année : 2021

Evaluation of TTV replication as a biomarker of immune checkpoint inhibitors efficacy in melanoma patients

Résumé

Torque Teno Virus (TTV) is a small, non-enveloped, single-stranded and circular DNA virus that infects the majority of the population worldwide. Increased levels of plasma TTV viral load have been observed in various situations of immune deficiency or dysregulation, and several studies have suggested that TTV levels may be inversely correlated with immune competence. The measurement of TTV viremia by qPCR has been proposed as a potential biomarker for the follow-up of functional immune competence in immunosuppressed individuals, particularly hematopoietic stem cell transplant recipients. We hypothesized that TTV viral load could be used as a prognostic marker of immune checkpoint inhibitor (ICI) efficacy, and therefore investigated the TTV viral load in melanoma patients treated with nivolumab or pembrolizumab before and after 6 months of treatment. In the present study, TTV viral load was not different in melanoma patients before anti-PD-1 introduction compared to healthy volunteers, was not modified by ICI treatment and did not allowed to distinguish patients with treatment-sensitive tumor from patients with treatment-resistant tumor.

Fichier principal
Vignette du fichier
5eea0cbb54f9975a8c84be8fa05b948b.pdf (692.52 Ko) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte
Licence

Dates et versions

hal-04880060 , version 1 (01-09-2025)

Licence

Identifiants

Citer

Rémi Pescarmona, William Mouton, Thierry Walzer, Stéphane Dalle, Anaïs Eberhardt, et al.. Evaluation of TTV replication as a biomarker of immune checkpoint inhibitors efficacy in melanoma patients. PLoS ONE, 2021, 16 (8), pp.e0255972. ⟨10.1371/journal.pone.0255972⟩. ⟨hal-04880060⟩
955 Consultations
116 Téléchargements

Altmetric

Partager

  • More